ReviewAdvanced healthcare materials2026
Platelet-Collagen Interactions in Hemostatic Mechanisms.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Platelet-Collagen Interactions in Hemostatic Mechanisms.Advanced healthcare materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Collagen exposure after endothelial disruption functions as a critical molecular signal for platelet adhesion and activation, which in turn supports thrombin generation and fibrin formation. As the extracellular matrix's predominant constituent, collagen provides the fundamental surface for clotting initiation. The interactions of specific platelet receptors with collagen are central to initiating and maintaining hemostasis. These receptors include glycoprotein VI (GPVI), the glycoprotein Ib-IX-V complex, and integrins such as α2β1 and αIIbβ3, with von Willebrand factor serving as a key ligand. However, systematic reviews of these specific receptor collagen interactions are relatively scarce. Although considerable progress has been made in elucidating these mechanisms, ongoing research continues to uncover additional regulatory complexity. This review systematically examines the binding mechanisms, signaling pathways, and functional roles of GPVI, vWF, and integrins in thrombus formation. This review also examines the role of other collagen types, such as types IV, VI, XV, and XVIII, in maintaining vascular integrity and supporting hemostasis. Finally, we highlight current research limitations and future directions, underscoring the need to validate collagen receptor interactions experimentally and develop novel antithrombotic therapies that target these pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.